Univercell-Biosolutions launches center of expertise with industrial and standardized approach to hiPSc cell line production

The center of expertise offers quality control and process management applied to a large panel of standardized products based on the Pluri-one® platform (more…)

Acquisition of iPS Cell Patent license from iPS Academia Japan

Non-exclusive worldwide licence will enable Univercell-Biosolutions to produce human cardiomyocytes for efficacy and toxicology testing (more…)